Abstract
Conclusion: Zinc supplementation is an
effective, safe and feasible therapy for
asthenospermic infertile males. It was associated
with significant increase in sperm motility. (Rawal
Med J 202;45:99-102).
Results: Total 90 infertile males were included in
study. Mean age of patients was 33.09±4.93
years. Baseline percent sperm motility was
2.05±3.33 and after 3 months percent sperm
motility was 26.76±12.9SD (t=8.827, df=88,
p=0.0000). Efficacy of zinc therapy is significantly
associated with marriage duration (p<0.05) and
insignificantly associated with age (p>0.05)
Methodology: This descriptive study was
conducted at Department of Urology, PAEC
hospital, Islamabad from May 2015 to November
2015. WHO calculator was utilized for sample size
calculation and Non probability sampling was
used. Married males, age-18-50 years and lab
findings showing asthenospermia were included
in the study. Patients were provided with 20 mg
zinc sulphate (per day) for time period of 3 months.
Semen analysis was done for pre and post
treatment sperm motility. Data were analyzed in
SPSS. Comparison was done with independent t
test and association was measured with ChiObjective:
